Niagen Bioscience, Inc. - Common Stock (NAGE)

CUSIP: 171077407

Q2 2024 13F Holders as of 30 Jun 2024

Type / Class
Equity / Common Stock
Shares outstanding
79,963,455
Total 13F shares
16,528,410
Share change
+3,388,874
Total reported value
$45,123,441
Put/Call ratio
21%
Price per share
$2.73
Number of holders
77
Value change
+$8,628,734
Number of buys
47
Number of sells
30

Quarterly Holders Quick Answers

What is CUSIP 171077407?
CUSIP 171077407 identifies NAGE - Niagen Bioscience, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of NAGE - Niagen Bioscience, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Chau Hoi Shuen Solina Holly
3/4/5
10%+ Owner
class O/S missing
19,294,356
$27,205,042 30 Sep 2022
Champion River Ventures Ltd
3/4/5
Director, 10%+ Owner
class O/S missing
11,408,715
$16,086,288 06 Sep 2023
VANGUARD GROUP INC
13F
Company
3.8%
3,048,119
$10,607,454 31 Mar 2024
13F
Tieton Capital Management, LLC
13F
Company
3.8%
3,021,875
$10,516,000 31 Mar 2024
13F
ICONIQ Capital, LLC
13F
Company
1.6%
1,296,354
$4,511,312 31 Mar 2024
13F
BlackRock Finance, Inc.
13F
Company
1.1%
902,953
$3,142,276 31 Mar 2024
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.73%
584,282
$2,033,301 31 Mar 2024
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.7%
561,059
$1,952,948 31 Mar 2024
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.48%
383,700
$1,335,000 31 Mar 2024
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.34%
269,603
$938,218 31 Mar 2024
13F
GAMCO INVESTORS, INC. ET AL
13F
Company
0.33%
263,850
$918,198 31 Mar 2024
13F
JANE STREET GROUP, LLC
13F
Company
0.29%
228,235
$794,257 31 Mar 2024
13F
GABELLI FUNDS LLC
13F
Company
0.25%
200,000
$696,000 31 Mar 2024
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.24%
192,225
$668,943 31 Mar 2024
13F
STATE STREET CORP
13F
Company
0.24%
190,239
$662,032 31 Mar 2024
13F
ROYAL BANK OF CANADA
13F
Company
0.23%
185,000
$644,000 31 Mar 2024
13F
Connor, Clark & Lunn Investment Management Ltd.
13F
Company
0.17%
133,066
$463,070 31 Mar 2024
13F
HRT FINANCIAL LP
13F
Company
0.16%
130,845
$455,000 31 Mar 2024
13F
Cambridge Investment Research Advisors, Inc.
13F
Company
0.15%
123,300
$429,000 31 Mar 2024
13F
Qube Research & Technologies Ltd
13F
Company
0.15%
121,339
$422,260 31 Mar 2024
13F
NORTHERN TRUST CORP
13F
Company
0.13%
100,318
$349,106 31 Mar 2024
13F
Silverberg Bernstein Capital Management LLC
13F
Company
0.1%
82,157
$285,906 31 Mar 2024
13F
Bank of New York Mellon Corp
13F
Company
0.09%
70,527
$245,434 31 Mar 2024
13F
CITIGROUP INC
13F
Company
0.08%
62,869
$218,784 31 Mar 2024
13F
Point72 Asia (Singapore) Pte. Ltd.
13F
Company
0.08%
60,691
$211,205 31 Mar 2024
13F
OneDigital Investment Advisors LLC
13F
Company
0.07%
55,317
$192,503 31 Mar 2024
13F
JPMORGAN CHASE & CO
13F
Company
0.06%
48,982
$170,457 31 Mar 2024
13F
Brevan Howard Capital Management LP
13F
Company
0.06%
48,026
$167,130 31 Mar 2024
13F
MORGAN STANLEY
13F
Company
0.06%
44,756
$155,751 31 Mar 2024
13F
WOLVERINE TRADING, LLC
13F
Company
0.06%
44,119
$153,534 31 Mar 2024
13F
CITADEL ADVISORS LLC
13F
Company
0.05%
41,033
$142,795 31 Mar 2024
13F
PERRITT CAPITAL MANAGEMENT INC
13F
Company
0.05%
40,000
$139,200 31 Mar 2024
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
0.05%
39,300
$137,000 31 Mar 2024
13F
Y-Intercept (Hong Kong) Ltd
13F
Company
0.05%
39,301
$136,767 31 Mar 2024
13F
LPL Financial LLC
13F
Company
0.05%
37,791
$131,513 31 Mar 2024
13F
Squarepoint Ops LLC
13F
Company
0.05%
36,461
$126,884 31 Mar 2024
13F
PRUDENTIAL FINANCIAL INC
13F
Company
0.03%
25,800
$89,784 31 Mar 2024
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.03%
24,667
$85,841 31 Mar 2024
13F
AXXCESS WEALTH MANAGEMENT, LLC
13F
Company
0.03%
22,834
$79,462 31 Mar 2024
13F
Crestwood Advisors Group, LLC
13F
Company
0.03%
21,948
$76,379 31 Mar 2024
13F
NewEdge Advisors, LLC
13F
Company
0.03%
21,415
$74,523 31 Mar 2024
13F
Kestra Advisory Services, LLC
13F
Company
0.03%
21,000
$73,080 31 Mar 2024
13F
ExodusPoint Capital Management, LP
13F
Company
0.03%
20,930
$73,000 31 Mar 2024
13F
Midwest Professional Planners, LTD.
13F
Company
0.03%
20,950
$72,906 31 Mar 2024
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.03%
20,411
$71,030 31 Mar 2024
13F
UBS Group AG
13F
Company
0.03%
20,023
$69,680 31 Mar 2024
13F
TWO SIGMA SECURITIES, LLC
13F
Company
0.02%
19,851
$69,081 31 Mar 2024
13F
OPPENHEIMER & CO INC
13F
Company
0.02%
19,600
$68,208 31 Mar 2024
13F
ACADIAN ASSET MANAGEMENT LLC
13F
Company
0.02%
19,461
$67,000 31 Mar 2024
13F
BALYASNY ASSET MANAGEMENT L.P.
13F
Company
0.02%
17,990
$62,605 31 Mar 2024
13F

Institutional Holders of Niagen Bioscience, Inc. - Common Stock (NAGE) as of Q2 2024

As of 30 Jun 2024, Niagen Bioscience, Inc. - Common Stock (NAGE) was held by 77 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 16,528,410 shares. The largest 10 holders included VANGUARD GROUP INC, BlackRock Inc., Tieton Capital Management, LLC, ICONIQ Capital, LLC, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, RENAISSANCE TECHNOLOGIES LLC, JPMORGAN CHASE & CO, GAMCO INVESTORS, INC. ET AL, and WINTON GROUP Ltd. This page lists 77 institutional shareholders reporting positions in this security for the Q2 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2024 vs Q1 2024 Across Filers

Q1 2024 holders
65
Q2 2024 holders
77
Holder diff
12
Investor Q1 2024 Shares Q2 2024 Shares Share Diff Share Chg % Q1 2024 Value $ Q2 2024 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .